Skip to content

Evaluation of Pro root-MTA, Biodentine and Theracal in partial pulpotomy of human dental healthy pulp.

Clinical, radiological and histological evaluation of Pro root-MTA, Biodentine and Theracal in partial pulpotomy of human dental healthy pulp.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015082420004N2
Enrollment
30
Registered
2016-02-10
Start date
2015-09-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vital pulp therapy..

Interventions

Intervention 1: In first group, Biodentin will be used for partial pulpotomy. Biodentin is new calcium silicate-based that is bioactive and non-toxic as demonstrated on human pulp cells. One single do
Treatment - Other
In the second groupe, Theracal will be used for partial pulpotomy. Theracal is also a new light-cured resin-modified calcium silicate-filled base/liner material, which sets in 20 seconds. Theracal con
In first group, Biodentin will be used for partial pulpotomy. Biodentin is new calcium silicate-based that is bioactive and non-toxic as demonstrated on human pulp cells. One single dose of liquid wil
Pro root-MTA will be used for partial pulpotomy in control group. it is a water based_material compound with bismuth oxide, tricalcium and dicalcium silicate and tricalcium aluminate. Open a pouch of

Sponsors

Vice chancellor for research, Islamic Azad dental university of Tehran.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 32 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:age(18-32 years)? erupted third molar? closed apex? caries free? normal sign to vitality tests Exclusion criteria: external or internal resorptin? periapical lesion

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pulp health( Post Operative sensitivity and pain ). Timepoint: After treatment, 1 weak later and before extraction. Method of measurement: Vitality tests, cold test and EPT.;Signs of periapical pathology. Timepoint: Radiographs are taken before intervention and extraction. Method of measurement: PA radiography.

Secondary

MeasureTime frame
Dentine barrier formation. Timepoint: 8 weeks after beginning treatment. Method of measurement: Histologic examination after extraction.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Hengameh Bakhtiar

Islamic Azad dental university of Tehran.

H_bakhtiar@dentaliau.ac.ir+98 21882027056

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026